Simvastatin improves disturbed endothelial barrier function

Circulation

Volumn 102, Issue 23, 2000, Pages 2803-2809

  Van Nieuw Amerongen, G P ^a   Vermeer, M A ^a   Negre Aminou, P ^a   Lankelma, J ^a   Emeis, J J ^a   Van Hinsbergh, V W M ^a  

^a TNO   (Netherlands)

Author keywords

Cells; Endothelium; Statins; Thrombin

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN;

ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL SYNTHESIS; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY THROMBOSIS; DRUG EFFECT; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0034610474     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.cir.102.23.2803     Document Type: Article

References (26)

1. Statins do more than just lower cholesterol
2. A tale of two trials: The West of Scotland Coronary Prevention Study and the Texas Coronary Atherosclerosis Prevention Study
3. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia
4. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease
5. Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within a month
6. Alterations in endothelial F-actin microfilaments in rabbit aorta in hypercholesterolemia
7. Transfer of low density lipoprotein into the arterial wall and the risk of atherosclerosis
8. The endothelial contractile cytoskeleton
9. Transient and prolonged increase in endothelial permeability induced by histamine and thrombin: Role of protein kinases, calcium, and RhoA
10. Stress fibres take shape
11. Expression of cGMP-dependent protein kinase I and phosphorylation of its substrate, vasodilator-stimulated phosphoprotein, in human endothelial cells of different origin
12. Passage of low density lipoproteins through monolayers of human arterial endothelial cells: Effects of vasoactive substances in an in vitro model
13. Separation of plasma lipoproteins by density-gradient ultracentrifugation
14. Endothelial permeability for macromolecules: Mechanistic aspects of pathophysiological modulation
15. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase
16. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors
17. cGMP and nitric oxide modulate thrombin-induced endothelial permeability: Regulation via different pathways in human aortic and umbilical vein endothelial cells
18. Thrombin inactivates myosin light chain phosphatase via Rho and its target Rho kinase in human endothelial cells
19. Activation of RhoA by thrombin in endothelial hyperpermeability: Role of Rho kinase and protein tyrosine kinases
20. Dissociation of LPA-induced cytoskeletal contraction from stress fiber formation by differential localization of RhoA
21. 3-Hydroxy-3-methylglutaryl coenzyme A reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture
22. Role of Rho protein in lovastatin-induced breakdown of actin cytoskeleton
23. Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors: Comparison with other human cell types
24. Control of systemic capillary leak syndrome with aminophylline and terbutaline
25. Simvastatin inhibits leukocyteendothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats
26. Long-term endothelial dysfunction is more pronounced after stenting than after balloon angioplasty in porcine coronary arteries